We are live on ! Find out more
CA

Capital Advantage Portfolio holdings

AUM $820M
1-Year Est. Return 20.6%
This Fund
S&P 500
This Quarter Est. Return
-1.77%
1 Year Est. Return
+20.6%
3 Year Est. Return
+44.41%
5 Year Est. Return
+43.97%
10 Year Est. Return
AUM
$192M
AUM Growth
+$10.6M
Cap. Flow
+$14.2M
Cap. Flow %
7.4%
Top 10 Hldgs %
79.37%
Holding
57
New
1
Increased
26
Reduced
11
Closed
1
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
T icon
26
AT&T
T
$177B
$784K 0.41%
29,448
+186
+0.6% +$4.95K
PG icon
27
Procter & Gamble
PG
$333B
$720K 0.38%
8,598
+662
+8% +$54.2K
IVV icon
28
iShares Core S&P 500 ETF
IVV
$897B
$666K 0.35%
3,361
-30
-0.9% -$5.97K
MCK icon
29
McKesson
MCK
$104B
$594K 0.31%
3,050
CSCO icon
30
Cisco
CSCO
$433B
$544K 0.28%
21,607
+27
+0.1% +$679
PEP icon
31
PepsiCo
PEP
$192B
$416K 0.22%
4,465
+6
+0.1% +$548
PFE icon
32
Pfizer
PFE
$159B
$408K 0.21%
14,528
-134
-0.9% -$3.76K
SHY icon
33
iShares 1-3 Year Treasury Bond ETF
SHY
$25.4B
$403K 0.21%
4,773
-5,464
-53% -$462K
AMZN icon
34
Amazon
AMZN
$2.86T
$401K 0.21%
24,880
+5,920
+31% +$98.5K
MCD icon
35
McDonald's
MCD
$186B
$355K 0.19%
3,744
MRK icon
36
Merck
MRK
$364B
$345K 0.18%
6,098
+4
+0.1% +$225
VZ icon
37
Verizon
VZ
$208B
$321K 0.17%
6,424
+2
+0% +$99
TWTR
38
DELISTED
Twitter, Inc.
TWTR
$306K 0.16%
5,941
QCOM icon
39
Qualcomm
QCOM
$174B
$291K 0.15%
3,895
+1
+0% +$76
AMGN icon
40
Amgen
AMGN
$233B
$288K 0.15%
2,054
+1
+0% +$131
TEVA icon
41
Teva Pharmaceuticals
TEVA
$42.6B
$288K 0.15%
5,351
IBM icon
42
IBM
IBM
$222B
$268K 0.14%
1,478
UNP icon
43
Union Pacific
UNP
$183B
$255K 0.13%
2,352
KO icon
44
Coca-Cola
KO
$387B
$253K 0.13%
5,920
AXP icon
45
American Express
AXP
$225B
$239K 0.12%
2,729
-200
-7% -$18K
VFH icon
46
Vanguard Financials ETF
VFH
$13.9B
$232K 0.12%
4,992
DIS icon
47
Walt Disney
DIS
$186B
$231K 0.12%
2,596
BA icon
48
Boeing
BA
$165B
$225K 0.12%
1,765
MMM icon
49
3M
MMM
$89.9B
$223K 0.12%
1,883
WBA
50
DELISTED
Walgreens Boots Alliance
WBA
$219K 0.11%
3,698

Similar funds

Capital Advantage's Q3 2014 Portfolio in Review

As of Q3 2014, Capital Advantage held 57 positions worth $192M, up 5.9% from $181M the previous quarter. Its ten largest holdings account for 79% of the portfolio.

Capital Advantage deployed $14.2M of net new capital in Q3 2014, opening 1 new position and adding to 26 existing holdings. Its largest new stake was Bristol-Myers Squibb: 3,965 shares worth $203K.

By sector, the portfolio is most concentrated in Miscellaneous at 87% of assets, up from 87% a quarter earlier, followed by Technology and Energy.

On the sell side, the largest reduction was Vanguard Short-Term Corporate Bond ETF, an estimated $1.06M trimmed.

  • Capital Advantage's largest Q3 2014 buy was Bristol-Myers Squibb: 3,965 shares worth $203K.
  • Capital Advantage added most to Invesco BulletShares 2018 Corporate Bond ETF in Q3 2014, an estimated $3.12M increase.
  • Capital Advantage's biggest Q3 2014 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $1.06M.
  • Capital Advantage fully exited iShares MSCI Emerging Markets Min Vol Factor ETF in Q3 2014, selling an estimated $211K.
  • Capital Advantage's ten largest holdings make up 79% of its $192M portfolio in Q3 2014.
  • Capital Advantage opened 1 new position and closed 1 in Q3 2014.
  • Capital Advantage's portfolio value rose 5.9% quarter-over-quarter to $192M.

Based on Capital Advantage's 13F filing for Q3 2014, filed 22 Jun 2016.